Degradation chemistry of gemcitabine hydrochloride, a new antitumor agent.
The anti-tumor agent gemcitabine hydrochloride, a beta-difluoronucleoside, is remarkably stable in the solid state. In 0.1 N HCI solution at 40 degrees C, deamination of gemcitabine occurs, yielding its uridine analogue. Approximately 86% of the initial gemcitabine remains after 4 weeks under these conditions. Cleavage of the N-glycosidic bond of gemcitabine or conversion to its alpha-anomer in 0.1 N HCI solution is not observed over a 4-week period. However, this work has shown that gemcitabine hydrochloride anomerizes in 0.1 N NaOH at 40 degrees C. Approximately 72% of the initial gemcitabine remains after 4 weeks under the basic conditions used. Uridine hydrolysis products are also formed under these conditions. The anormerization reaction, which is unusual under basic conditions, has been confirmed by characterization of the chromatographically isolated alpha-anomer by NMR and mass spectrometry. A mechanism involving an acyclic intermediate is proposed.
Anliker
S L
SL
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285.
McClure
M S
MS
Britton
T C
TC
Stephan
E A
EA
Maple
S R
SR
Cooke
G G
GG
D000964:Antimetabolites, Antineoplastic / Q000737:chemistry*; D002851:Chromatography, High Pressure Liquid; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000737:chemistry; D004355:Drug Stability; D006863:Hydrogen-Ion Concentration; D007536:Isomerism; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D012996:Solutions; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D012996:Solutions; D003841:Deoxycytidine; D000093542:Gemcitabine